Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 251 | Taragenyx | Series Unknown | $1.0M | Glasgow, United Kingdom |
| 252 | i2Eye Diagnostics | Series Unknown | $775K | Edinburgh, United Kingdom |
| 253 | Relitect | Seed | $1.1M | Glasgow, United Kingdom |
| 254 | TeamRock | Grant | $1.0M | London, United Kingdom |
| 255 | Waveblade | Series Unknown | $930K | Port Angeles, United States |
| 256 | Opinurate | Seed | $1.0M | Glasgow, United Kingdom |
| 257 | TPP Global Development | Series A | $12.2M | Edinburgh, United Kingdom |
Regenerating orthopedic and dental implant design to help patients heal faster with far less pain.
i2eye diagnostics is a spin-out company from the University of Edinburgh and the Edinburgh BioQuarter.
Relitect is developing a novel assay platform for the label free electrochemical detection of binding events.
TeamRock Radio is a commercial-free national DAB rock radio station broadcasting in the UK.
Wavecraft is a Port Angeles-based provider of wholesale marine electronic equipment.
Opinurate is a software company which specialises in building solutions for organisations to understand their customer's experiences.
TPP Global Development is a preclinical stage drug development company focused on nervous system disorders, immunology, and oncology.
Scottish Enterprise has invested in 257 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Scottish Enterprise's top investment sectors include Biotechnology, Health Care, Health Diagnostics, Dental, Medical. The firm invests across 17 different industry categories.
Among tracked funding rounds, TPP Global Development received $12.2M in a Series A round. Scottish Enterprise's total known invested capital is $809.1M.
Scottish Enterprise's average investment size is $4.0M across its portfolio of 257 companies.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors